Effects of commercial preparations of pangamic acid (B15) on exercised rats.
D000818:Animals; D002125:Calcium Gluconate; D004304:Dosage Forms; D006003:Glycogen / Q000032:analysis; D008099:Liver / Q000032:analysis; D008112:Liver Glycogen; D008297:Male; D008930:Mitochondria, Liver / Q000201:enzymology; D009132:Muscles / Q000032:analysis; D034442:N-substituted Glycines; D010089:Oxidoreductases, N-Demethylating / Q000032:analysis; D005082:Physical Exertion / Q000187:drug effects*; D011437:Propylamines; D011506:Proteins / Q000032:analysis; D051381:Rats; D050892:Sarcosine Dehydrogenase; D013385:Succinate Dehydrogenase / Q000032:analysis; D014803:Vitamin B Complex / Q000008:administration & dosage / Q000494:pharmacology*
D004304:Dosage Forms; D008112:Liver Glycogen; D034442:N-substituted Glycines; D011437:Propylamines; D011506:Proteins; D014803:Vitamin B Complex; D006003:Glycogen; D013385:Succinate Dehydrogenase; D010089:Oxidoreductases, N-Demethylating; D050892:Sarcosine Dehydrogenase; C494397:Sardh protein, rat; C105565:pangamic acid; D002125:Calcium Gluconate